115 related articles for article (PubMed ID: 26175400)
1. Prospects in cancer immunotherapy: treating advanced stage disease or preventing tumor recurrence?
Manjili MH; Payne KK
Discov Med; 2015 Jun; 19(107):427-31. PubMed ID: 26175400
[TBL] [Abstract][Full Text] [Related]
2. Immunotherapy of cancer: targeting cancer during active disease or during dormancy?
Shah SA; Zarei M; Manjili SH; Guruli G; Wang XY; Manjili MH
Immunotherapy; 2017 Sep; 9(11):943-949. PubMed ID: 29338608
[TBL] [Abstract][Full Text] [Related]
3. The inherent premise of immunotherapy for cancer dormancy.
Manjili MH
Cancer Res; 2014 Dec; 74(23):6745-9. PubMed ID: 25411346
[TBL] [Abstract][Full Text] [Related]
4. Veterinary Oncology Immunotherapies.
Bergman PJ
Vet Clin North Am Small Anim Pract; 2018 Mar; 48(2):257-277. PubMed ID: 29224713
[TBL] [Abstract][Full Text] [Related]
5. Cellular immunotherapy in ovarian cancer: Targeting the stem of recurrence.
Wefers C; Lambert LJ; Torensma R; Hato SV
Gynecol Oncol; 2015 May; 137(2):335-42. PubMed ID: 25727651
[TBL] [Abstract][Full Text] [Related]
6. Recent developments in therapeutic cancer vaccines.
Morse MA; Chui S; Hobeika A; Lyerly HK; Clay T
Nat Clin Pract Oncol; 2005 Feb; 2(2):108-13. PubMed ID: 16264883
[TBL] [Abstract][Full Text] [Related]
7. Intravesical chemo-immunotherapy in non muscle invasive bladder cancer.
Leopardo D; Cecere SC; Di Napoli M; Cavaliere C; Pisano C; Striano S; Marra L; Menna L; Claudio L; Perdonà S; Setola S; Berretta M; Franco R; Tambaro R; Pignata S; Facchini G
Eur Rev Med Pharmacol Sci; 2013 Aug; 17(16):2145-58. PubMed ID: 23893180
[TBL] [Abstract][Full Text] [Related]
8. Dendritic cell immunotherapy in ovarian cancer.
Stiff PJ; Czerlanis C; Drakes ML
Expert Rev Anticancer Ther; 2013 Jan; 13(1):43-53. PubMed ID: 23259426
[TBL] [Abstract][Full Text] [Related]
9. A paradigm shift in therapeutic vaccination of cancer patients: the need to apply therapeutic vaccination strategies in the preventive setting.
Gray A; Raff AB; Chiriva-Internati M; Chen SY; Kast WM
Immunol Rev; 2008 Apr; 222():316-27. PubMed ID: 18364011
[TBL] [Abstract][Full Text] [Related]
10. Cancer vaccines: emphasis on pediatric cancers.
Guinipero T; Finn OJ
Curr Pharm Des; 2010 Jan; 16(3):292-9. PubMed ID: 20109138
[TBL] [Abstract][Full Text] [Related]
11. [Immunotherapy of superficial bladder tumors in a hospital department].
Prekopp G; Rosdy E
Orv Hetil; 1993 Dec; 134(50):2757-60. PubMed ID: 8265124
[TBL] [Abstract][Full Text] [Related]
12. Vaccine studies demonstrate promise of immunotherapy to treat breast cancer and prevent recurrence.
Oncology (Williston Park); 2000 Oct; 14(10):1415-6. PubMed ID: 11098507
[No Abstract] [Full Text] [Related]
13. Treatment of biochemical recurrence of prostate cancer with granulocyte-macrophage colony-stimulating factor secreting, allogeneic, cellular immunotherapy.
Urba WJ; Nemunaitis J; Marshall F; Smith DC; Hege KM; Ma J; Nguyen M; Small EJ
J Urol; 2008 Nov; 180(5):2011-7; discussion 2017-8. PubMed ID: 18801509
[TBL] [Abstract][Full Text] [Related]
14. On immunotherapies and cancer vaccination protocols: a mathematical modelling approach.
Joshi B; Wang X; Banerjee S; Tian H; Matzavinos A; Chaplain MA
J Theor Biol; 2009 Aug; 259(4):820-7. PubMed ID: 19446568
[TBL] [Abstract][Full Text] [Related]
15. Dendritic cell-based immunotherapy targeting Wilms' tumor 1 in patients with recurrent malignant glioma.
Sakai K; Shimodaira S; Maejima S; Udagawa N; Sano K; Higuchi Y; Koya T; Ochiai T; Koide M; Uehara S; Nakamura M; Sugiyama H; Yonemitsu Y; Okamoto M; Hongo K
J Neurosurg; 2015 Oct; 123(4):989-97. PubMed ID: 26252465
[TBL] [Abstract][Full Text] [Related]
16. Active specific immunotherapy for stage II and stage III human colon cancer: a randomised trial.
Vermorken JB; Claessen AM; van Tinteren H; Gall HE; Ezinga R; Meijer S; Scheper RJ; Meijer CJ; Bloemena E; Ransom JH; Hanna MG; Pinedo HM
Lancet; 1999 Jan; 353(9150):345-50. PubMed ID: 9950438
[TBL] [Abstract][Full Text] [Related]
17. Adjuvant therapy in gastric cancer: can we prevent recurrences?
Meyerhardt JA; Fuchs CS
Oncology (Williston Park); 2003 May; 17(5):714-21, 728; discussion 728-9, 732-3. PubMed ID: 12800796
[TBL] [Abstract][Full Text] [Related]
18. [Results obtained by intravesical instillation of BCG in superficial bladder tumors].
Romics I; Dietmar B; Christoph R
Orv Hetil; 1990 Jan; 131(1):25-8. PubMed ID: 2405331
[TBL] [Abstract][Full Text] [Related]
19. [The immunotherapy of bladder tumors and the immunoprophylaxis of disease recurrence].
Korovin AI; Savvin VT
Urol Nefrol (Mosk); 1996; (1):19-21. PubMed ID: 8659034
[TBL] [Abstract][Full Text] [Related]
20. A case of recurrent ovarian cancer successfully treated with adoptive immunotherapy and lentinan.
Fujimoto K; Tomonaga M; Goto S
Anticancer Res; 2006; 26(6A):4015-8. PubMed ID: 17195451
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
